Common immune checkpoints, exemplified by programmed death 1(PD-1), upon binding with programmed cell death-ligand 1(PDL-1), are typically expressed on the surface of tumor cells, orchestrating the inhibition of T cell proliferation and activation, thereby facilitating the evasion of tumor cells from immune surveillance (167). This evidence concerns the gene CD274 and neoplasm.